New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
The global sales of microbial identification are estimated to be worth USD 4.69 billion in 2025 and anticipated to reach a ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...
Recognized as a 2025 Top Innovations pick in the Biotechnology category, AVITI24 from Element Biosciences enables true ...
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care ...
Zacks Investment Research on MSN
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback